BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 8, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 29, 2009
View Archived Issues
Partial responses to interleukin-21 seen in ongoing phase II metastatic melanoma study
Read More
Bevacizumab safe in first 300 patients enrolled in phase III melanoma trial
Read More
Bazedoxifene coupled with conjugated estrogens improves menopausal symptoms in 3 phase III trials
Read More
2009 an important year for Protalix Biotherapeutics' pGlcCerase
Read More
Novel VEGFR-2 inhibitors identified by Santen for the treatment of cancer
Read More
Rituximab safe and effective as rescue therapy in idiopathic systemic vasculitis patients
Read More
Japan Tobacco presents free fatty acid receptor 1 agonists as antidiabetics
Read More
Novel antibacterial agents described by Prolysis
Read More
Merck & Co. claims T-type calcium channel blockers as antiepileptic drugs
Read More
Germany to fund clinical research in colorectal cancer using Epigenomics' mSEPT9
Read More
KB-R7943 provides neuroprotection in model of ischemic injury of CNS white matter
Read More
Hematide increases hemoglobin response in chronic kidney disease patients; phase II trial suggests
Read More
Nanowired-based delivery of H-290/51 confers neuroprotection in rat model of heat stroke
Read More
Sciele Pharma acquires global rights for PSD-502 from Plethora Solutions
Read More
CureVac commences mRNA vaccine clinical study in non-small cell lung cancer
Read More
Medinox reports clinical results for naproxen prodrug, LT-NS001
Read More
Emisphere reports data from oral GLP-1 and PYY3-36 with Eligen technology
Read More
Senesco's Factor 5A1 siRNA improves survival in H1N1-infected mice
Read More
FDA extends review timeline for Centocor's BLA for Stelara for plaque psoriasis
Read More
AEG-35156 displays evidence of clinical activity in first-in-man phase I trial in cancer patients
Read More
THRX-200495 confers in vivo bronchoprotection via both muscarinic and beta2-adrenergic receptors
Read More
Neutrophil elastase inhibitor POL-6014 shows preclinical potential for the treatment of lung disease
Read More
FDA files for standard review Warner Chilcott's NDA for oral contraceptive WC-3016
Read More
Neoprobe commences second phase III Lymphoseek trial
Read More
Companies commence Nexavar/Tarceva combination trial in liver cancer
Read More
ImmuneRegen submits IND to FDA to initiate human clinical testing of Homspera
Read More
EMEA validates Gilead's MAA for regadenoson for radionuclide MPI
Read More